Charles River Laboratories, Inc.

Charles River Laboratories International, Inc. is a globally recognized contract research organization (CRO) specializing in preclinical and clinical laboratory services that advance the development of new drugs, vaccines, and medical devices. Founded in 1947 by Henry Foster and headquartered in Wilmington, Massachusetts, Charles River supports pharmaceutical, biotechnology, and medical device companies worldwide, including operations in Miami and over 20 countries.

With a workforce of more than 20,100 employees and annual revenues of $4.05 billion in 2024, Charles River Laboratories is a leader in non-clinical research services. The company’s broad portfolio of products and commitment to scientific innovation help accelerate drug discovery and improve global health outcomes.

When Was Charles River Laboratories Founded?

Founded: 1947
Founder: Henry Foster
Headquarters: Wilmington, Massachusetts, USA
Industry: Pharmaceuticals, Biotechnology, Gene Therapy, Cell Therapy, Medical Devices, Contract Research
Employees: 20,100+ globally
Annual Revenue: $4.05 billion (2024)
Global Locations: 80+ facilities in 15 countries including Miami

Charles River Laboratories Mission Statement

“To provide essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts.”

What Is Charles River Laboratories Known For?

Charles River Laboratories is widely recognized for delivering comprehensive preclinical and clinical research solutions that support the entire drug discovery and development continuum, setting the standard in contract research organization services.

Comprehensive Drug Discovery Support

The company’s wide array of products and laboratory services spans from early-stage discovery to regulatory toxicology studies, enabling clients to advance new therapies efficiently and with scientific rigor.

Market Leadership in Non-Clinical Research

Charles River holds a strong market position providing animal research models, microbial testing, and toxicology services crucial for regulatory submissions to authorities such as the U.S. Food and Drug Administration (FDA).

Commitment to Scientific Excellence and Innovation

Investment in cutting-edge technologies like next-generation sequencing and genetically engineered animal models highlights the company’s dedication to advancing research methodologies and therapeutic innovation.

How Many Locations Does Charles River Laboratories Operate?

Charles River operates over 80 facilities across 15 countries worldwide, with a presence in major pharmaceutical and biotech hubs including Miami. Their global footprint allows them to serve a diverse client base with localized expertise and service delivery.

This extensive infrastructure supports the company’s ability to provide integrated laboratory services spanning nonclinical to clinical research phases.

Where Are Charles River’s Key Locations?

Headquartered in Wilmington, Massachusetts, Charles River also maintains numerous sites in the United States and internationally across Europe, Asia, and the Americas, including strategic operations in Miami to support the region’s growing biotech industry.

Who Owns Charles River Laboratories?

Charles River Laboratories International, Inc. is a publicly traded company listed on the NASDAQ stock exchange. Ownership is distributed among institutional investors, individual shareholders, and company insiders.

Is Charles River Laboratories Currently Hiring?

You can check out the open positions that Charles River Laboratories has right here on OysterLink.